Prosight Management, LP
Source: SEC Form 13F · as of Mar 2026Prosight Management, LP holds 20 biotech & pharma companies tracked by BioSniper, totaling $182.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$182.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for NEKTAR THERAPEUTICS (NKTR)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| NKTRNEKTAR THERAPEUTICS | 735,000 | $52.9M |
| KURAKura Oncology, Inc. | 3,356,700 | $27.3M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 76,000 | $25.1M |
| ZYMEZymeworks Inc. | 539,049 | $13.5M |
| ABVXAbivax SA | 105,000 | $11.7M |
| TERNTerns Pharmaceuticals, Inc. | 202,300 | $10.7M |
| OKUROnKure Therapeutics, Inc. | 2,154,381 | $8.9M |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | 697,108 | $6.5M |
| ROIVRoivant Sciences Ltd. | 180,000 | $5.0M |
| IMVTImmunovant, Inc. | 175,825 | $4.4M |
| TECXTectonic Therapeutic, Inc. | 79,872 | $2.5M |
| RCKTRocket Pharmaceuticals Inc. | 683,856 | $2.4M |
| UPBUpstream Bio, Inc. | 241,123 | $2.2M |
| PLRXPLIANT THERAPEUTICS, INC. | 1,667,600 | $2.1M |
| ANTXAN2 Therapeutics, Inc. | 515,754 | $1.8M |
| ACETAdicet Bio, Inc. | 250,244 | $1.7M |
| RGNXREGENXBIO Inc. | 200,000 | $1.7M |
| VKTXViking Therapeutics, Inc. | 45,000 | $1.5M |
| PVLAPALVELLA THERAPEUTICS, INC. | 5,000 | $623K |
| RNTXRein Therapeutics, Inc. | 411,600 | $535K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.